Crow Point Partners’s GSK GSK Stock Holding History

Crow Point Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-501	Closed	-$27K	–	297
2016 Q3	$27K	Buy	+501	New	+$27.5K	﹤0.01%	271
2015 Q3	$42K	Buy	864 +176	+26%	+$9.16K	0.01%	228
2015 Q2	$36K	Buy	688 +480	+231%	+$27K	0.01%	230
2015 Q1	$12K	Buy	+208	New	+$11.9K	﹤0.01%	216
2014 Q3	$11K	Sell	192 -6,272	-97%	-$385K	﹤0.01%	227
2014 Q2	$432K	Hold	6,464	–	–	0.06%	132
2014 Q1	$432K	Buy	+6,464	New	+$437K	0.06%	132

Other funds holding GSK

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of New York Mellon

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return